Identification of genes differentially expressed in human hepatocellular carcinoma by a modified suppression subtractive hybridization method

International Journal of Cancer

Volumn 112, Issue 2, 2004, Pages 239-248

  Dong, Xue Yuan ^a   Pang, Xue Wen ^a   Yu, Song Tao ^a   Su, Yan Rong ^a   Wang, Hong Chen ^a   Yin, Yan Hui ^a   Wang, Yue Dan ^a   Chen, Wei Feng ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

CT antigen; Differentially expressed genes; HCC specific gene; Hepatocellular carcinoma; Modified SSH

Indexed keywords

ACUTE PHASE PROTEIN; COMPLEMENTARY DNA; DNA FRAGMENT; PLASMA PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL METABOLISM; CELL PROLIFERATION; DATA BASE; GENE EXPRESSION; GENE IDENTIFICATION; GENE REPRESSION; GENETIC CODE; HUMAN; HUMAN CELL; HYBRIDIZATION; LIVER; LIVER CELL CARCINOMA; METASTASIS; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; SAMPLE; TECHNIQUE; TUMOR SUPPRESSOR GENE; UNINDEXED SEQUENCE;

ACUTE-PHASE PROTEINS; BLOOD PROTEINS; BLOTTING, NORTHERN; CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION; LIVER NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 4644353887     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20363     Document Type: Article

References (42)

1. Freedman AN. Somatic alterations and metabolic polymorphisms. IARC Sci Publ 1999;148:37-50.
2. Okuda K. Hepatocellular carcinoma. J Hepatol 2000;32:225-37.
3. Compagni A, Christofori G. Recent advances in research on multi-stage tumorigenesis. Br J Cancer 2000;83:1-5.
4. Kondoh N, Wakatsuki T, Hada A, Shuda M, Tanaka K, Arai M, Yamamoto M. Genetic and epigenetic events in human hepatocarcinogenesis. Int J Oncol 2001;18:1271-8.
5. Dominguez-Malagon H, Gaytan-Graham S. Hepatocellular carcinoma: an update. Ultrastruct Pathol 2001;25:497-516.
6. Kondoh N, Wakatsuki T, Hada A, Shuda M, Tanaka K, Arai M, Yamamoto M. Genetic and epigenetic events in human hepatocarcinogenesis. Int J Oncol 2001;18:1271-8.
7. Luo G, Huang S, Xie X, Stockert E, Chen YT, Kubuschok B, Pfreundschuh M. Expression of cancer-testis genes in human hepatocellular carcinomas. Cancer Immunol 2002;2:11.
8. Wang Y, Han KJ, Pang XW, Vaughan HA, Qu W, Dong XY, Peng JR, Zhao HT, Rui JA, Leng XS, Cebon J, Burgess AW, Chen WF. Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies. J Immunol 2002;169:1102-9.
9. Oyamada M, Krutovskikh VA, Mesnil M, Partensky C, Berger F, Yamasaki H. Aberrant expression of gap junction gene in primary human hepatocellular carcinomas: increased expression of cardiac-type gap junction gene connexin 43. Mol Carcinog 1990;3:273-8.
10. Chen X, Cheung ST, So S, Fan ST, Barry C, Higgins J, Lai KM, Ji J, Dudoit S, Ng IO, Van De Rijn M, Botstein D, et al. Gene expression patterns in human liver cancers. Mol Biol Cell 2002;13:1929-39.
11. Xu XR, Huang J, Xu ZG, Qian BZ, Zhu ZD, Yan Q, Cai T, Zhang X, Xiao HS, Qu J, Liu F, Huang QH, et al. Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci U S A 2001;98:15089-94.
12. Xu L, Hui L, Wang S, Gong J, Jin Y, Wang Y, Ji Y, Wu X, Han Z, Hu G. Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma. Cancer Res 2001;61:3176-81.
13. Okabe H, Satoh S, Kato T, Kitahara O, Yanagawa R, Yamaoka Y, Tsunoda T, Furukawa Y, Nakamura Y. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res 2001;61:2129-37.
14. Kos J, Krasovec M, Cimerman N, Nielsen HJ, Matcher Christensen IJ, Brunner N. Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis. Clin Cancer Res 2000;6:505-11.
15. Sho M, Adachi M, Taki T, Hashida H, Konishi T, Huang CL, Ikeda N, Nakajima Y, Kanehiro H, Hisanaga M, Nakano H, Miyake M. Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer. Int J Cancer 1998;79:509-16.
16. Manohar CF, Salwen HR, Brodeur GM, Cohn SL. Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma. Genes Chromosomes Cancer 1995;14:196-203.
17. Hufton SE, Moerkerk PT, Brandwijk R, de Bruine Matcher AP, Arends JW, Hoogenboom HR. A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization. FEBS Lett 1999;463:77-82.
18. Montgomerie JZ, Gracy RW, Holshuh HJ, Keyser AJ, Bennett CJ, Schick DG. The 28K protein in urinary bladder, squamous metaplasia and urine is triosephosphate isomerase. Clin Biochem 1997;30:613-8.
19. Lu R, Serrero G. Inhibition of PC cell-derived growth factor (PCDGF, epithelin/granulin precursor) expression by antisense PCDGF cDNA transfection inhibits tumorigenicity of the human breast carcinoma cell line MDA-MB-468. Proc Natl Acad Sci U S A 2000;97:3993-8.
20. Mathur S, Cleary KR, Inamdar N, Kim YH, Steck P, Frazier ML. Overexpression of elongation factor-1gamma protein in colorectal carcinoma. Cancer 1998;82:816-21.
21. Otsuki T, Yamada O, Yata K, Sakaguchi H, Kurebayashi J, Nakazawa N, Taniwaki M, Yawata Y, Ueki. Expression of fibroblast growth factor and FGF-receptor family genes in human myeloma cells, including lines possessing t(4; 14)(q16.3;q32. 3) and FGFR3 translocation. Int J Oncol 1999;15:1205-12.
22. Yamamoto T, Gotoh M, Sasaki H, Terada M, Kitajima M, Hirohashi S. Molecular cloning and initial characterization of a novel fibrinogen-related gene, HFREP-1. Biochem Biophys Res Commun 1993;193:681-7.
23. Wu CG, Hakvoort TB, Lamers WH, Chamuleau RA. Isolation of up- and down-regulated cDNAs associated with hepatocellular carcinoma by a subtraction-enhanced display technique. Biochim Biophys Acta 1996;1315:169-75.
24. Betts JC, Edbrooke MR, Thakker RV, Woo P. The human acute-phase serum amyloid A gene family: structure, evolution and expression in hepatoma cells. Scand J Immunol 1991;34:471-82.
25. Shao J, Li Y, Li H, Wu Q, Hou J, Liew C. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas. Chin Med J 2000;113:817-22.
26. Meliconi R, Parracino O, Facchini A, Morselli-Labate AM, Bortolotti F, Tremolada F, Martuzzi M, Miglio F, Gasbarrini G. Acute phase proteins in chronic and malignant liver diseases. Liver 1988;8:65-74.
27. Ishii H, Baffa R, Numata SI, Murakumo Y, Rattan S, Inoue H, Mori M, Fidanza V, Alder H, Croce CM. The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors. Proc Nat Acad Sci U S A 1999;96:3928-3933.
28. Shimomura K, Sakakura C, Fujita Y, Nakanishi M, Hagiwara A, Yamagishi H. Overexpression of 14-3-3 in primary gastric cancers and clinical application for the detection of micrometastases in the peritoneal cavity. Nippon Geka Gakkai Zasshi 2002;103:386.
29. Furstenberger G, Senn HJ. Insulin-like growth factors and cancer. Lancet Oncol 2002;3:298-302.
30. Wang Y, Cheong D, Chan S, Hooi SC. Ribosomal protein L7a gene is up-regulated but not fused to the tyrosine kinase receptor as chimeric trk oncogene in human colorectal carcinoma. Int J Oncol 2000;16:757-62.
31. Daly M, O'Meara A, Hallinan FM. Identification and characterization of a new antithrombin III familial variant (AT Dublin) with possible increased frequency in children with cancer. Br J Haematol 1987;65:457-62.
32. Zou TT, Selaru FM, Xu Y, Shustova V, Yin J, Mori Y, Shibata D, Sato F, Wang S, Olaru A, Deacu E, Liu TC, et al. Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon. Oncogene 2002;21:4855-62.
33. Heerdt BG, Halsey HK, Lipkin M, Augenlicht LH. Expression of mitochondrial cytochrome c oxidase in human colonic cell differentiation, transformation, and risk for colonic cancer. Cancer Res 1990;50:1596-600.
34. Satterwhite E, Sonoki T, Willis TG, Harder L, Nowak R, Arriola EL, Liu H, Price HP, Gesk S, Steinemann D, Schlegelberger B, Oscier DG, et al. The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. Blood 2001;98:3413-20.
35. Kim JW, Wang XW. Gene expression profiling of preneoplastic liver disease and liver cancer: a new era for improved early detection and treatment of these deadly diseases? Carcinogenesis 2003;24:363-9.
36. Nakamura T, Yamazaki Y, Saiki Y, Moriyama M, Largaespada DA, Jenkins NA, Copeland NG. Evi9 encodes a novel zinc finger protein that physically interacts with BCL6, a known human B-cell protooncogene product. Mol Cell Biol 2000;20:3178-86.
37. Dear TN. Cloning, structure, expression analysis, and assignment to mouse chromosome 7 of the gene Zfp296 encoding a zinc finger protein. Mamm Genome 2000;11:1037-9.
38. Scanlan MJ, Gordon CM, Williamson B, Lee SY, Chen YT, Stockert E, Jungbluth A, Ritter G, Jager D, Jager E, Knuth A, Old LJ. Identification of cancer/testis genes by database mining and mRNA expression analysis. Int J Cancer 2002;98:485-92
39. Luo G, Huang S, Xie X, Stockert E, Chen YT, Kubuschok B, Pfreundschuh M. Expression of cancer-testis genes in human hepatocellular carcinomas. Cancer Immunol 2002;19;2:11.
40. Ishii H, Vecchione A, Murakumo Y, Baldassarre G, Numata S, Trapasso F, Alder H, Baffa R, Croce CM. FEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth and regulates mitosis. Proc Nat Acad Sci U S A 2001;98:10374-10379.
41. Hannon GJ, Beach D. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 1994;371:257-61.
42. Stone S, Dayananth P, Jiang P, Weaver-Feldhaus JM, Tavtigian SV, Cannon-Albright L, Kamb A. Genomic structure, expression and mutational analysis of the P15 (MTS2) gene. Oncogene 1995;11:987-91.